vTv Therapeutics CFO Steven Tuch to resign effective March 21, 2025

vTv Therapeutics Inc.

Steven Tuch, EVP and CFO, informed company of resignation on Feb 24, 2025.
Departure is not due to any disagreement with auditors or management.
Company has begun external search for a successor; Tuch will stay through 10-K filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Steven Tuch

Executive Vice President and Chief Financial Officer

VTVT · vTv Therapeutics Inc.

Effective: 2025-03-21
Filed: February 27, 2025, 6:59 PM ET

On February 24, 2025, Steven Tuch, Executive Vice President and Chief Financial Officer of vTv Therapeutics Inc. (the "Company"), informed the Company of his intention to resign from his position effective March 21, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Steven Tuch resigned as Executive Vice President and Chief Financial Officer at vTv Therapeutics Inc..

Action: resigned
Role: Executive Vice President and Chief Financial Officer

Exact text from the filing

On February 24, 2025, Steven Tuch, Executive Vice President and Chief Financial Officer of vTv Therapeutics Inc. (the "Company"), informed the Company of his intention to resign from his position effective March 21, 2025.

View on SEC.gov

vTv Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001641489-25-000005

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.